The CCK2R is an example of a GPCR with therapeutic potential for the treatment of gastrointestinal disorders including cancer. Cyclotides are nature-derived peptides that represent an emerging class of GPCR modulators. This evidence concerns the gene CCKBR and digestive system disorder.